İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

correvio - ceftobiprole medocaril sodium - powder for concentrate for solution for infusion - 500 milligram(s) - other cephalosporins and penems; ceftobiprole medocaril

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

correvio australia pty ltd - tirofiban hydrochloride, quantity: 0.0562 mg/ml (equivalent: tirofiban, qty 0.05 mg/ml) - injection, solution - excipient ingredients: sodium chloride; sodium citrate dihydrate; citric acid; sodium hydroxide; hydrochloric acid; water for injections - aggrastat, in combination with heparin, is indicated for patients with unstable angina or non-q-wave myocardial infarction to prevent cardiac ischaemic events.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

correvio australia pty ltd - tirofiban hydrochloride, quantity: 0.0562 mg/ml (equivalent: tirofiban, qty 0.05 mg/ml) - injection, solution - excipient ingredients: sodium hydroxide; citric acid; water for injections; sodium citrate dihydrate; sodium chloride; hydrochloric acid - aggrastat, in combination with heparin, is indicated for patients with unstable angina or non-q-wave myocardial infarction to prevent cardiac ischaemic events.

Malta - İngilizce - Medicines Authority

correvio (uk) limited - tirofiban hydrochloride monohydrate 50 µg/ml - solution for infusion

Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

correvio uk ltd - ceftobiprole medocaril sodium - powder for solution for infusion - 500mg

Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

correvio uk ltd - dalbavancin hydrochloride - powder for solution for infusion - 500mg

Belçika - İngilizce - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

correvio - tirofiban hydrochloride 281 µg/ml - eq. tirofiban 250 µg/ml - concentrate for solution for infusion - 0,25 mg/ml - tirofiban hydrochloride 281 µg/ml - tirofiban

Belçika - İngilizce - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

correvio - tirofiban hydrochloride 56,18 µg/ml - eq. tirofiban 50 µg/ml - solution for infusion - 0,05 mg/ml - tirofiban hydrochloride 56.18 µg/ml - tirofiban

İsrail - İngilizce - Ministry of Health

tzamal bio-pharma ltd - vernakalant hydrochloride - concentrate for solution for infusion - vernakalant hydrochloride 20 mg/ml - vernakalant - vernakalant - rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults who are hemodynamically stable.- for non-surgery patients: atrial fibrillation ≤ 7 days duration- for post-cardiac surgery patients: atrial fibrillation ≤ 3 days duration

Avrupa Birliği - İngilizce - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - dalbavancin hydrochloride - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, - treatment of acute bacterial skin and skin structure infections (absssi) in adults.